London, UK – 2 April 2015: Oxford BioMedica plc (“Oxford BioMedica” or “the Group”) (LSE:OXB), a leading gene and cell therapy group, gives notice that copies of the 2014 Annual Report…
London, UK – 20 March 2015: Oxford BioMedica plc (“Oxford BioMedica” or “the Company”) (LSE:OXB), a leading gene and cell therapy company, announces that Dr Paul Blake, Chief Development Officer, will…
You have selected Encore.Encore is InterCall’s recording replay service and provides the opportunity to listen to the Event for those who were unable to attend it live or who would…
Oxford, UK – 13 March 2015: Oxford BioMedica plc (LSE: OXB), (“OXB” or “the Group”) a leading gene and cell therapy group, today announces its preliminary results for the twelve…
Results date: – 13 March 2015: Oxford, UK – 6 March 2015: Oxford BioMedica plc (LSE: OXB), (“OXB” or “the Company”) a leading gene and cell therapy company, will be announcing…
Oxford, UK – 5 March 2015: Oxford BioMedica plc (LSE: OXB), (“OXB” or “the Company”) a leading gene and cell therapy company, announces that Tim Watts, Chief Financial Officer, will present…
London, UK – 3 March 2015: Oxford BioMedica plc (“Oxford BioMedica” or “the Company”) (LSE:OXB), a leading gene and cell therapy company, announces that John Dawson, Chief Executive Officer, and Tim…
Oxford, UK – 23 February 2015: Oxford BioMedica plc (LSE: OXB), (“OXB” or “the Company”) a leading gene and cell therapy company, today welcomed the Rt Hon Danny Alexander, Chief…
Biotech Showcase™ is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical…
Oxford, UK – 3 November 2014: Oxford BioMedica plc (“Oxford BioMedica” or “the Company”) (LSE: OXB), a leading gene and cell therapy company, today publishes its interim management statement for the…
Oxford, UK – 13 October 2014: Oxford BioMedica plc (“Oxford BioMedica” or “the Company”) (LSE: OXB), a leading gene and cell therapy company, announces that it has acquired the freehold of…
Oxford, UK – 10 October 2014: Oxford BioMedica plc (LSE: OXB), (“OXB” or “the Group”) a leading gene and cell therapy company, announces today that it has signed further contracts with…